NEW YORK, Jan. 19, 2024 /PRNewswire/ — On January 18, 2024, the Opioid Master Disbursement Trust II (“MDT II”) won a key, opening victory in its case against Covidien Unlimited Company, a subsidiary of Medtronic and Mallinckrodt’s former parent, and three of its subsidiaries…
Opioid Master Disbursement Trust II Wins Key Opening Victory in Covidien Litigation
This post was originally published on this site